Advanced Filters
noise
Found 1,604 clinical trials

Cardiometabolic Health in First Time Pregnancy

Women who experience placental complications (syndromes) during pregnancy, such as pre-eclampsia (high blood pressure and kidney problems), gestational hypertension (high blood pressure during pregnancy) and fetal growth restriction (baby being small) have twice the risk of developing heart disease and diabetes later in life, compared to women who have a …

18 - 45 years of age Female Phase N/A
K Kiyuk Chang

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Prospective trials performed on type 2 diabetes patients without established cardiovascular disease has shown that SGLT2 inhibitors reduce cardiovascular risk. No studies have yet examined the occurrence of cardiovascular disease in patients with acute myocardial infarction. The investigators designed the current study to evaluate the most ideal oral hypoglycemic agent …

19 years of age All Phase N/A
R Rebecca Harris, BMedSci, BMBS

Nottingham Community Liver Biomarkers Cohort

Deaths due to advanced liver scarring (liver cirrhosis) continue to increase, and liver disease is now the 3rd leading cause of premature death in the United Kingdom. The majority of liver disease is lifestyle related (alcohol, obesity and associated type 2 diabetes, injecting drug use) and therefore reversible if caught …

18 years of age All Phase N/A
C Clinical Study Center

Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients

The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of …

18 - 69 years of age All Phase N/A
S Sahar Khodabakhsh, PhD

Chronotype of Patients With Diabetes and Effect on Glycaemic Control

The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.

18 - 75 years of age All Phase N/A
K Kelsie LaFerriere

The T1D Exchange Registry

The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on …

years of age All Phase N/A
S Sofia Carlsson, PhD

Mortality and Cardiovascular Diseases in Adult-onset Type 1 Diabetes

Scarce evidence is available for prognosis in adult-onset type 1 diabetes (T1D). The aim of this study is to investigate the risk of all-cause mortality, cause-specific mortality, and incident CVD in adult-onset T1D, as compared to type 2 diabetes with comparable age at diagnosis and population controls. We will explore …

18 - 110 years of age All Phase N/A
G Ghazal Peerwani

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults

Coronary heart disease (CHD) is a major cause of morbidity, disability, mortality, and health expenditures worldwide. A wealth of studies has demonstrated that people of South Asian ancestry have a higher risk of CHD and particularly premature CHD than most other racial/ethnic groups, and recent research suggests that this risk …

35 - 65 years of age All Phase N/A
J Jinjun Chen, PHD

Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes

This study is aimed at calculating the incidence of nonalcoholic fatty liver disease (NAFLD), non- alcoholic steatohepatitis (NASH) cirrhosis and advanced fibrosis in patients with type 2 diabetes in China, evaluating the diagnostic efficacy of FibroTouch for hepatic steatosis and fibrosis in these patients, analyzing the long-term prognosis and screening …

18 years of age All Phase N/A
Z Zhou Zhang, MD,PhD

China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)

Type 2 diabetes (T2D) and dementia are both diseases with increasing incidence and prevalence globally, leading to substantial economic burdens for families and society. Notably, diabetes significantly increases the risk of cognitive dysfunction, which is classified into preclinical stage, mild cognitive impairment and dementia based on the disease severity. Cognitive …

45 years of age All Phase N/A

Simplify language using AI